Cytosorbents Future Growth
Future criteria checks 2/6
Cytosorbents is forecast to grow earnings and revenue by 63.9% and 20.9% per annum respectively while EPS is expected to grow by 68.1% per annum.
Key information
63.9%
Earnings growth rate
68.1%
EPS growth rate
Medical Equipment earnings growth | 17.5% |
Revenue growth rate | 20.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 04 Nov 2024 |
Recent future growth updates
Recent updates
The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More
Oct 01Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)
Jul 04Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
Mar 16Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper
Jan 06Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?
Nov 10Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price
Jul 13Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
May 16We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 08CytoSorbents secures $4.3M contract by U.S. Department of Defense
Oct 06CytoSorbents stock rises on US DoD contract to develop device for universal plasma
Sep 09We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Sep 02CytoSorbents gets reimbursement for CytoSorb in Turkey
Aug 23CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system
Aug 17Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M
Aug 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 55 | -3 | -12 | -11 | 3 |
12/31/2025 | 47 | -9 | -21 | -20 | 3 |
12/31/2024 | 40 | -16 | -26 | -26 | 3 |
6/30/2024 | 37 | -26 | -22 | -21 | N/A |
3/31/2024 | 37 | -28 | -24 | -23 | N/A |
12/31/2023 | 36 | -29 | -23 | -22 | N/A |
9/30/2023 | 37 | -23 | -22 | -21 | N/A |
6/30/2023 | 36 | -26 | -24 | -22 | N/A |
3/31/2023 | 35 | -31 | -30 | -23 | N/A |
12/31/2022 | 35 | -33 | -35 | -28 | N/A |
9/30/2022 | 36 | -41 | -36 | -28 | N/A |
6/30/2022 | 38 | -36 | -34 | -26 | N/A |
3/31/2022 | 41 | -29 | -24 | -20 | N/A |
12/31/2021 | 43 | -25 | -18 | -14 | N/A |
9/30/2021 | 44 | -16 | -12 | -10 | N/A |
6/30/2021 | 45 | -10 | -11 | -9 | N/A |
3/31/2021 | 43 | -9 | -7 | -5 | N/A |
12/31/2020 | 41 | -8 | -7 | -6 | N/A |
9/30/2020 | 36 | -11 | -10 | -9 | N/A |
6/30/2020 | 32 | -17 | -12 | -11 | N/A |
3/31/2020 | 28 | -18 | -17 | -16 | N/A |
12/31/2019 | 25 | -19 | -18 | -17 | N/A |
9/30/2019 | 24 | -21 | -17 | -15 | N/A |
6/30/2019 | 23 | -17 | -14 | -13 | N/A |
3/31/2019 | 23 | -19 | -14 | -13 | N/A |
12/31/2018 | 23 | -17 | -12 | -11 | N/A |
9/30/2018 | 21 | -15 | -10 | -9 | N/A |
6/30/2018 | 19 | -14 | -10 | -8 | N/A |
3/31/2018 | 17 | -10 | N/A | -7 | N/A |
12/31/2017 | 15 | -9 | N/A | -6 | N/A |
9/30/2017 | 14 | -11 | N/A | -7 | N/A |
6/30/2017 | 12 | -10 | N/A | -7 | N/A |
3/31/2017 | 11 | -11 | N/A | -7 | N/A |
12/31/2016 | 10 | -12 | N/A | -7 | N/A |
9/30/2016 | 8 | -9 | N/A | -8 | N/A |
6/30/2016 | 7 | -10 | N/A | -8 | N/A |
3/31/2016 | 6 | -5 | N/A | -8 | N/A |
12/31/2015 | 5 | -9 | N/A | -9 | N/A |
9/30/2015 | 4 | -17 | N/A | -9 | N/A |
6/30/2015 | 4 | -17 | N/A | -9 | N/A |
3/31/2015 | 4 | -21 | N/A | -8 | N/A |
12/31/2014 | 4 | -19 | N/A | -6 | N/A |
9/30/2014 | 4 | -9 | N/A | -5 | N/A |
6/30/2014 | 4 | -8 | N/A | -4 | N/A |
3/31/2014 | 3 | -7 | N/A | -3 | N/A |
12/31/2013 | 2 | -7 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CTSO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CTSO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CTSO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CTSO's revenue (20.9% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CTSO's revenue (20.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CTSO's Return on Equity is forecast to be high in 3 years time